Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Over two days, the Burbank hospital hosted activities to pay tribute to the resilience and heritage of the Armenian community ...

A vomiting-free ward protocol significantly reduced the effects of nausea and vomiting on QOL, anxiety, and depression, in patients with gynecologic cancers receiving chemotherapy.

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be ...

To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), ...

a physician and gynecologic oncologist at Yale Cancer Center in Connecticut. This pervasive spread makes it much harder to contain or eradicate the disease. Stage 0 cancer is different from ...

Cancer is not going away. As the U.S. population ages, the burden of cancer on society will only grow. Disparities in treatment access and outcomes persist across race, income and geography. And ...

Tina Knowles’ breast cancer diagnosis highlights a critical issue: many early-stage cancers are only caught through routine ...